ABIONYX Pharma
About
What does ABIONYX Pharma do?
ABIONYX Pharma is a next-generation biopharmaceutical company focused on developing innovative therapies for sepsis and intensive care. Their approach is based on a proprietary technology platform utilizing apoA-I.
What is ABIONYX Pharma's revenue?
StartupHub estimates ABIONYX Pharma's annual revenue at $65.9M (range $36.1M to $170.5M, 44% confidence), based on comparable companies in the sector.
What is ABIONYX Pharma's valuation?
StartupHub estimates ABIONYX Pharma's effective valuation at $1.0B (range $734.6M to $1.4B, 42% confidence), based on comparable companies in the sector.
How much funding has ABIONYX Pharma raised?
ABIONYX Pharma has raised a total of $225M in funding. The most recent round on record is Capital Increase.
Where is ABIONYX Pharma headquartered?
ABIONYX Pharma is headquartered in Toulouse, France.
When was ABIONYX Pharma founded?
ABIONYX Pharma was founded in 2015.
What industry does ABIONYX Pharma operate in?
ABIONYX Pharma operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, MedTech, HealthTech.
No comments yet. Be the first to share your take.